The observer-blind, randomised controlled study to determine the safety and immunogenicity of "Covishield" on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.
source https://timesofindia.indiatimes.com/india/phase-2-trial-of-oxford-covid-19-vaccine-candidate-set-to-begin-from-today/articleshow/77733969.cms
source https://timesofindia.indiatimes.com/india/phase-2-trial-of-oxford-covid-19-vaccine-candidate-set-to-begin-from-today/articleshow/77733969.cms
Comments
Post a Comment